What is the effect of Amlodipine 2.5mg during the trough period, especially in the last hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amlodipine 2.5mg Trough Effect and Last-Hour Coverage

Amlodipine 2.5mg maintains effective blood pressure control throughout the entire 24-hour dosing interval, including the trough period in the last hours before the next dose, due to its exceptionally long elimination half-life of 40-60 hours. 1

Pharmacokinetic Profile Supporting Trough Coverage

Amlodipine's unique pharmacokinetic properties ensure minimal fluctuation between peak and trough levels:

  • The elimination half-life of 40-60 hours results in only 20-25% fluctuation in plasma drug concentration between doses with once-daily administration 1
  • Peak plasma concentrations occur 6-8 hours after dosing, with gradual onset of effect that prevents reflex tachycardia 1
  • Steady-state is achieved over 1-1.5 weeks of once-daily dosing, with no tendency for drug accumulation even in patients with renal dysfunction 1, 2

Blood Pressure Control During Trough Period

Clinical evidence demonstrates sustained antihypertensive effect throughout the 24-hour dosing interval:

  • In clinical trials, maintenance of blood pressure effect over the entire 24-hour dosing interval was observed, with little difference between peak and trough effect 3
  • Ambulatory blood pressure monitoring studies show significant reductions in all time periods including the last six-hour dosing interval 4
  • The JNC 7 guidelines specifically note that blood pressure should be measured just prior to dosing to determine if satisfactory control is obtained, and that amlodipine is dosed once daily 5

Trough Effect Considerations

While amlodipine generally maintains 24-hour coverage, monitoring for trough effect is still recommended:

  • The JNC 7 guidelines acknowledge that "in some patients treated once daily, the antihypertensive effect may diminish toward the end of the dosing interval (trough effect)" 5
  • If inadequate trough control is identified, an increase in dosage (from 2.5mg to 5mg or 10mg) should be considered rather than increasing frequency 5
  • The usual dose range for amlodipine is 2.5-10mg once daily, with 2.5mg being the minimum effective dose 5, 6

Evidence Against Divided Dosing

Dividing amlodipine doses provides no additional benefit:

  • A crossover study comparing amlodipine 10mg once daily versus 5mg twice daily found no significant differences in 24-hour, daytime, nighttime, or early morning blood pressure control 7
  • Trough plasma amlodipine concentrations were not significantly different between once-daily and twice-daily administration (20.57 vs 22.37 ng/mL) 7
  • The long half-life makes divided dosing pharmacologically unnecessary 1, 7

Clinical Monitoring Recommendations

To assess trough coverage adequacy:

  • Measure blood pressure just prior to the next scheduled dose to evaluate trough control 5
  • Consider 24-hour ambulatory blood pressure monitoring if trough effect is suspected, particularly evaluating early morning blood pressure before dosing 4
  • If blood pressure goal is not met at trough, titrate upward to 5mg or 10mg once daily rather than splitting doses 5, 6

Special Populations

Amlodipine 2.5mg maintains efficacy in specific patient groups:

  • In pediatric patients aged 6-17 years, 2.5mg once daily is the recommended starting dose with demonstrated efficacy 5, 3
  • In patients with renal dysfunction, amlodipine 2.5-5mg daily maintains efficacy without drug accumulation or significant worsening of renal function 2
  • In elderly patients, dose initiation should be low and titrated cautiously, but once-daily dosing remains appropriate 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.